Lynwood Capital Management »

Briacell Therapeutics Corp shares owned by Lynwood Capital Management

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTX) shares owned by Lynwood Capital Management from 13F filings

Historical chart of Lynwood Capital Management investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by Lynwood Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by Lynwood Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.6M 1.6M 2.86
2023-12-31 $9.2M 1.6M 5.85

More positions owned by Lynwood Capital Management

Briacell Therapeutics Corp (BCTX)
Americas Gold And Silver Cor (USAS)
Vaneck Etf Trust Gold Miners Etf (GDX)
Altimmune Com New (ALT)
Immix Biopharma (IMMX)
Advanced Micro Devices (AMD)
Teck Resources CL B (TECK)
Petroleo Brasileiro Sa Petro Sponsored Adr (PBR)
Spire Global Com Cl A New (SPIR)
Sociedad Quimica Y Minera De Spon Adr Ser B (SQM)
Vermilion Energy (VET)
Lightspeed Commerce Sub Vtg Shs (LSPD)
Diamond Offshore Drilli (DO)
Mag Silver Corp (MAG)
Transocean Registered Shs (RIG)

View all positions for Lynwood Capital Management

Top funds holding Briacell Therapeutics Corp

Vontobel Holding
Hrt Financial
Citadel Advisors
Onyx Bridge Wealth Group
Group One Trading
Bank Of Montreal
Summit Trail Advisors
LPL Financial
XTX Topco
Cambridge Investment Research Advisors
HighTower Advisors
Susquehanna International
National Bank Of Canada /fi/
Concord Wealth Partners
Royal Bank of Canada

View all funds holding Briacell Therapeutics Corp